Profile of Jarrod Walsh
Jarrod has over 20 years experience in early stage pharmaceutical discovery working extensively with screening applications, assay development activities and biophysical technologies. Since 2012 he’s focused on devising approaches to identify and eliminate compounds that function via undesirable mechanisms of action to improve the quality of hit to lead compounds. His work interests include the application of biophysical techniques and development of new technologies to improve hit identification activities. Jarrod is currently an Associate Director in AstraZeneca’s Hit Discovery department.